Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 123 Million shares, which have been reported (via 13F filing form) to have a value of $56.5 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Group One Trading, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
20,515
shares
|
$9,436
0.0% of portfolio
|
Q4 2024
Reduced 57.59%
|
|
|
Rhumbline Advisers
Boston, MA |
Jan 30, 2025 Q4 2024 |
19,748
shares
|
$9,084
0.0% of portfolio
|
Q4 2024
Added 3.07%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
19,530
shares
|
$8,983
0.0% of portfolio
|
Q4 2024
Added 318.65%
|
|
|
Kingswood Wealth Advisors, LLC
San Diego, CA |
Jan 22, 2025 Q4 2024 |
18,690
shares
|
$8,597
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Clear Harbor Asset Management, LLC
|
Jan 16, 2025 Q4 2024 |
18,525
shares
|
$8,521
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Baader Bank Aktiengesellschaft
Unterschleissheim, 2M |
Jan 23, 2025 Q4 2024 |
18,095
shares
|
$8,323
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Pks Advisory Services, LLC
Albany, NY |
Feb 11, 2025 Q4 2024 |
17,000
shares
|
$7,820
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
16,563
shares
|
$7,618
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Columbia Advisory Partners LLC
|
Jan 13, 2025 Q4 2024 |
16,420
shares
|
$7,553
0.01% of portfolio
|
Q4 2024
Reduced 47.74%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
16,160
shares
|
$7,433
0.0% of portfolio
|
Q4 2024
Reduced 80.86%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
15,258
shares
|
$7,018
0.0% of portfolio
|
Q2 2024
Reduced 20.77%
|
|
|
X Square Capital, LLC
|
Feb 12, 2025 Q4 2024 |
11,173
shares
|
$5,139
0.0% of portfolio
|
Q4 2024
Reduced 0.06%
|
|
|
R Squared LTD
Central, K3 |
Jan 22, 2025 Q4 2024 |
8,770
shares
|
$4,034
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Global Retirement Partners, LLC
|
Jan 31, 2025 Q4 2024 |
6,000
shares
|
$2,760
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Lindbrook Capital, LLC
|
Feb 06, 2025 Q4 2024 |
4,610
shares
|
$2,120
0.0% of portfolio
|
Q4 2024
Reduced 4.89%
|
|
|
Cibc Private Wealth Group, LLC
|
Feb 12, 2025 Q4 2024 |
3,023
shares
|
$1,390
0.0% of portfolio
|
Q2 2024
Reduced 96.06%
|
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
3,023
shares
|
$1,390
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Sandy Spring Bank
|
Feb 11, 2025 Q4 2024 |
1,050
shares
|
$483
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Plante Moran Financial Advisors, LLC
|
Feb 05, 2025 Q4 2024 |
925
shares
|
$425
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Raiffeisen Bank International Ag
Vienna, C4 |
Feb 14, 2025 Q4 2024 |
907
shares
|
$417
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
Feb 13, 2025 Q4 2024 |
755
shares
|
$347
0.0% of portfolio
|
Q3 2024
Reduced 3.82%
|
|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
Jan 28, 2025 Q4 2024 |
604
shares
|
$277
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Carmichael Hill & Associates, Inc.
|
Oct 29, 2024 Q3 2024 |
525
shares
|
$241
0.0% of portfolio
|
Q1 2022
Added 50.0%
|
|
|
High Mark Wealth Management LLC
|
Jan 31, 2025 Q4 2024 |
287
shares
|
$132
0.0% of portfolio
|
Q3 2023
Reduced 77.38%
|
|
|
Parallel Advisors, LLC
|
Feb 10, 2025 Q4 2024 |
250
shares
|
$115
0.0% of portfolio
|
Q4 2024
Reduced 96.52%
|